The chemistry, biology and pharmacology of the cyclopentenone prostaglandins
| Autor: | Sumner Burstein |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
0301 basic medicine
Physiology Prostaglandin Inflammation 030204 cardiovascular system & hematology Pharmacology Biochemistry 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Neoplasms medicine Animals Humans Receptor Transcription factor Cyclopentenone prostaglandins chemistry.chemical_classification Cell Biology 030104 developmental biology chemistry Eicosanoid Prostaglandins Arachidonic acid medicine.symptom Polyunsaturated fatty acid |
| Zdroj: | Prostaglandinsother lipid mediators. 148 |
| ISSN: | 1098-8823 |
| Popis: | The cyclopentenone prostaglandins (CyPGs) are a small group compounds that are a subset of the eicosanoid superfamily, which are metabolites of arachidonic acid as well as other polyunsaturated fatty acids. The CyPGs are defined by a structural feature, namely, a five-membered carbocyclic ring containing an alfa-beta unsaturated keto group. The two most studied members are PGA2 and 15d-PGJ2 (15-deoxy-Δ12,14-prostaglandin J2); other less studied members are PGA1, Δ12-PGJ2, and PGJ2. They are involved in a number of biological activities including the ability to resolve chronic inflammation and the growth and survival of cells, particularly those of cancerous or neurological origin. Also, they can activate the prostaglandin DP2 receptor as well as the ligand-dependent transcription factor PPAR-gamma. Their ability to promote the resolution of chronic inflammation makes it of particular interest to have a good understanding of their actions. Since their discovery, the literature on the CyPGs has greatly expanded both in size and in scope; these reports are covered in the current review. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect